Moneycontrol PRO
you are here: HomeNewsIndia

Kerala reports over 30,000 cases for 3rd consecutive day; TPR at 19.22%

Meanwhile 18,573 persons recuperated from the disease on Friday, taking the total cured in the state to 37,30,198.

August 27, 2021 / 08:12 PM IST
Source: Reuters

Source: Reuters

Kerala continued to report over 30,000 cases for the third consecutive day on Friday and showed an increased Test Positivity Rate, while 179 deaths took the the toll to 20,313.

The state logged 32,801 cases today, up from 30,007 on Thursday. The figure was 31,445 cases on August 25. The number of samples tested in the last 24 hours increased to 1,70,703, health minister Veena George said, compared to 1,66,397 on Thursday. The Test Positivity Rate stood at 19.22 per cent, an increase from 18.03 on August 26.

"Out of those found infected today, 144 reached the state from outside while 31,281 contracted the disease from their contacts. The sources of infection of 1,260 are yet to be traced. Among the infected are 116 health workers, " the minister said in a release.

Among the districts, Malappuram reported the highest number of cases (4,032), followed by Thrissur 3,953 and Ernakulam 3,627, Kozhikode 3,362 and Kollam 2,828.

Meanwhile 18,573 persons recuperated from the disease on Friday, taking the total cured in the state to 37,30,198.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Currently, there are 1,95,254 persons under treatment in the state.

The health department said there are 353 wards across 70 local self government bodies where the weekly infection population ratio was above eight per cent.

The steady rise in cases had seen Union Home Secretary Ajay Bhalla review the situation with top officials on Thursday and the steps taken to contain the alarming graph of the virus in the state.

The central government had said that the southern state is the only one reporting over one lakh active COVID-19 cases, while four states have 10,000 to one lakh active cases and 31, less than 10,000 active cases.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Aug 27, 2021 08:11 pm
Sections
ISO 27001 - BSI Assurance Mark